MDM2 and neuroblastoma: In this context, it remains to be shown whether small compounds that selectively inhibit MDM2, such as nutlin-3, and that induce proliferation arrest and apoptosis in neuroblastoma cell lines [34,35] represent a new therapeutic option for high-risk neuroblastomas.